Journal
BIOACTIVE MATERIALS
Volume 1, Issue 2, Pages 109-121Publisher
KEAI PUBLISHING LTD
DOI: 10.1016/j.bioactmat.2016.09.004
Keywords
HIV; HIV treatment; Drug development; Peptide therapeutic; Peptide inhibitor
Ask authors/readers for more resources
Treatment of HIV has long faced the challenge of high mutation rates leading to rapid development of resistance, with ongoing need to develop new methods to effectively fight the infection. Traditionally, early HIV medications were designed to inhibit RNA replication and protein production through small molecular drugs. Peptide based therapeutics are a versatile, promising field in HIV therapy, which continues to develop as we expand our understanding of key protein-protein interactions that occur in HIV replication and infection. This review begins with an introduction to HIV, followed by the biological basis of disease, current clinical management of the disease, therapeutics on the market, and finally potential avenues for improved drug development. (C) 2016 The Authors. Production and hosting by Elsevier B.V. on behalf of KeAi Communications Co., Ltd.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available